3. The bad

11. The largest contributor to GDP is the services sector, comprising finance, insurance, real estate and business services

12. The South African Reserve Bank (SARB) has increased interest rates six times since the beginning of 2007, driven by monetary policy which targets an inflation band of 3% to 6%

13. Economic activity is experiencing a slowdown (in midst of global markets and domestic issues) following unprecedented growth over the past several years

14. As result of higher monetary policy and credit-lending criteria, household demand has decreased (following a period of easy access to credit in recent times)

15. With a large measure of macro stability achieved, the aim of economic policy is to lower unemployment and poverty through raising the growth potential of the economy

16. The Government continues to target 6% real GDP growth by 2010

19. The bad

22. Inequity / BEE

23. Service Delivery

24. Skills exodus / Skills Gap

25. Housing / sanitation / education

28. The bad

31. # 2 South Africa : 0.496008 = 25,000 = 68 murders/day

32. # 3 Jamaica: 0.324196

33. # 4 Venezuela: 0.316138

34. # 5 Russia: 0.201534

35. # 6 Mexico: 0.130213

36. # 7 Estonia: 0.107277

37. # 8 Latvia: 0.10393

38. # 9 Lithuania: 0.102863

41. MTC transmission 300,000 p.a.

42. HIV / AIDS deaths 345,000 p.a.

43. Tuberculosis 482,000

46. The bad

49. Dispensing Dr

53. Adcock – Ingram

54. Sanofi Aventis

55. Novartis

56. Pfizer

57. Astra-Zeneca

58. Johnson & Johnson

59. Roche

60. Glaxo

63. The bad

72. Niche, boutique

73. Shared trading infrastructure across principals

74. Cost effective

75. Dedicated marketing and sales forces

76. Principal directed product positioning

77. Integrated pharmaceutical agency offering

78. Registration, Marketing, Launch, Distribution, Regulatory, Finance

79. Regional (SADC) agency offering

83. Radiology

84. Dermatology

85. Gastro-Enterology

86. Oncology

87. Psychiatry

88. Clinical nutrition

89. Cardiology

90. Pain Management

91. Anaesthesiology

92. Allergology

97. In-depth knowledge of both R&D and generic Rx markets

98. Focused on Specialty Pharma and Hospital Business

99. Fastest growing and largest private pharma company in South Africa, now entering SADC countries